Agamree 40 mg/ml

Agamree 40 mg/ml is a medicine authorised by Swissmedic under authorisation number 69650. The authorisation holder is Santhera Pharmaceuticals (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 14 January 2026 and the authorisation is limited until 13 January 2031. ATC code H02AB18 places the medicine in the group Corticosteroids for systemic use.

  • Dispensing category A
  • Authorisation number 69650
  • ATC H02AB18
  • Synthetic medicines
Authorisation data
Authorisation number69650
NameAgamree 40 mg/ml
Full nameAgamree 40 mg/ml, Suspension zum Einnehmen
Authorisation holderSanthera Pharmaceuticals (Schweiz) AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeH02AB18
First authorisation14 January 2026
Authorisation validity13 January 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Agamree 40 mg/ml, Suspension zum EinnehmenA14 January 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1100mlH02AB1801.99.0.A

Scroll the table sideways

Frequently asked questions

Is Agamree 40 mg/ml authorised in Switzerland?

Yes. Agamree 40 mg/ml is authorised by Swissmedic under authorisation number 69650, data as of 01 September 2026. The authorisation is limited until 13 January 2031.

Which dispensing category does Agamree 40 mg/ml have?

Agamree 40 mg/ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Agamree 40 mg/ml?

The authorisation holder is Santhera Pharmaceuticals (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com